Muscle Loss After Menopause: What a Muscle Biopsy Study Found About the Collagen Scaffold

In this article - Why is muscle strength about more than muscle fibers? - What does the research say about muscle loss during the menopause transition? - What did the muscle biopsy study on shilajit actually find? - Does exercise alone solve this? - Common questions about muscle loss after menopause

Why is muscle strength about more than muscle fibers?

Picture a muscle fiber as a single rope. Now picture dozens of those ropes bundled together, wrapped in a mesh that holds the bundle's shape and carries the pulling force out to the tendon and the joint. That mesh is the extracellular matrix, built mostly from collagen, and without it a muscle can have plenty of fiber and still transmit force poorly.

This matrix is not static tissue. It is built and rebuilt by specific genes, and those genes respond to the body's hormonal environment, the same way skin and tendon collagen do. When the signal that keeps that rebuilding active weakens, the scaffold itself starts to thin, independent of how much muscle fiber a woman still has.

A few things depend on that scaffold working correctly:

• Force transmission. A muscle fiber contracts, but the surrounding collagen mesh is what carries that force to the tendon and ultimately to movement.
• Injury resistance. A weaker matrix is part of why strains and tears become more common with age, even in muscles that still look reasonably sized on a scan.
• Recovery speed. Rebuilding the matrix after a workout is part of what makes a muscle stronger over time, not just the fiber growth itself.
• Posture and joint stability. The same connective tissue wraps the muscles that hold a joint in place, not just the ones that move it.
• How a muscle looks on a scan. A scan reads fiber volume, not scaffold quality, so two women can look similar in size and differ in how well that size translates to usable strength.

What does the research say about muscle loss during the menopause transition?

A 2020 study published in the Journal of Clinical Medicine followed 234 women through the menopause transition, tracking body composition from perimenopause into early postmenopause. Researchers found significant decreases in lean body mass, appendicular lean mass, leg lean mass, and thigh muscle cross-sectional area.

Menopausal status itself was a significant predictor of these losses, measured separately from how physically active each woman was. Physical activity was an additional contributor, meaning it helped, but it did not erase the effect of the transition itself.

Here is a short setup for what the measured variables actually were:

• Lean body mass, the total weight of everything that isn't fat.
• Appendicular lean mass, lean tissue specifically in the arms and legs.
• Leg lean mass, measured separately since leg strength drives most daily function.
• Thigh muscle cross-sectional area, a direct size measurement, not an estimate.

Why this matters for how you read your own strength changes

A woman who trains consistently and still notices her strength sliding is not necessarily doing something wrong. The research shows menopausal status has its own independent effect on muscle, on top of whatever training is or isn't happening.

What did the muscle biopsy study on shilajit actually find?

An 8-week human trial, published in 2016, enrolled 16 overweight or class I obese adults, 10 women and 6 men, with a mean age of 35.7. Researchers took muscle tissue biopsies from the vastus lateralis, the large muscle on the front of the thigh, before and after 500 mg of shilajit daily.

The results were specific to the collagen scaffold, not the muscle fibers themselves. A cluster of 17 extracellular matrix genes was upregulated. Three numbers from the microarray give a sense of scale:

• COL3A1 rose 5.18 times over baseline.
• COL1A2 rose 5.13 times over baseline.
• COL1A1, the gene for type 1 collagen, rose 4.61 times on the microarray panel.

A separate RT-PCR validation, a more sensitive follow-up test, found an even larger shift for COL1A1 specifically, rising more than 80 times over its baseline level at the 8-week mark.

What this trial does and doesn't show

This was not a trial in postmenopausal women, and it measured gene expression, not strength or lean mass directly. Its value is narrower and more specific than a strength outcome. It is one of the few human studies to biopsy muscle tissue directly and show that shilajit acts on the exact collagen genes that build the structural scaffold muscle depends on, in real human muscle, not a cell dish or an animal model.

The researchers credit fulvic acid, the organic acid that makes up a large share of purified shilajit resin, as the likely driver, consistent with its documented role supporting collagen-producing cells elsewhere in the body.

Does exercise alone solve this?

Resistance training remains the single most studied way to slow muscle loss at any age, and nothing here replaces it. But the 2020 Finnish study's finding, that menopausal status predicted muscle loss independent of activity level, points to something training alone doesn't fully address.

Here is the short version of how the two approaches differ:

A muscle built from strong fibers but a thinning scaffold is still working at a disadvantage. Both pieces matter, and they are not interchangeable.

Optimum Shilajit

Optimum Shilajit is purified resin from the Altai mountains, standardized and third-party tested for heavy metals with results published rather than claimed. Two tablets with breakfast, made in small batches by a family-owned company based in Florida, backed by a 90-day money-back guarantee.

See Optimum Shilajit